Page last updated: 2024-10-21

cgp 52411 and Acute Confusional Senile Dementia

cgp 52411 has been researched along with Acute Confusional Senile Dementia in 5 studies

4,5-dianilinophthalimide: structure given in first source
4,5-dianilinophthalimide : Phthalimide substituted at the 4- and 5-positions by anilino groups.

Research Excerpts

ExcerptRelevanceReference
" We find that these protofibrils or fibrils are toxic to certain neuronal cells that carry Ca-permeant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors."1.32Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. ( Blanchard, BJ; Chen, A; Ingram, VM; Rozeboom, LM; Stafford, KA; Weigele, P, 2004)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duan, XH1
Qiao, JP1
Yang, Y1
Cui, MC1
Zhou, JN1
Liu, BL1
Blanchard, BJ2
Chen, A1
Rozeboom, LM2
Stafford, KA1
Weigele, P2
Ingram, VM2
Doggrell, SA1
Hennessy, EJ2
Buchwald, SL2
Wang, H1
Duennwald, ML1
Roberts, BE1
Zhang, YL1
Steele, AD1
Krishnan, R1
Su, LJ1
Griffin, D1
Mukhopadhyay, S1
King, J1
Deniz, AA1
Lindquist, S1
Shorter, J1

Reviews

1 review available for cgp 52411 and Acute Confusional Senile Dementia

ArticleYear
A small-molecule lead compound for the treatment of Alzheimer's disease.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:2

    Topics: Alzheimer Disease; Animals; Cell Line; Drugs, Investigational; Humans; Phthalimides

2005

Other Studies

4 other studies available for cgp 52411 and Acute Confusional Senile Dementia

ArticleYear
Novel anilinophthalimide derivatives as potential probes for beta-amyloid plaque in the brain.
    Bioorganic & medicinal chemistry, 2010, Volume: 18, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Brain; Humans; Mice; Phthalimi

2010
Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Oct-05, Volume: 101, Issue:40

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Calcium Signaling; Drug Evaluation, Preclinical; Humans; I

2004
Synthesis of 4,5-dianilinophthalimide and related analogues for potential treatment of Alzheimer's disease via palladium-catalyzed amination.
    The Journal of organic chemistry, 2005, Sep-02, Volume: 70, Issue:18

    Topics: Alzheimer Disease; Amination; Catalysis; Palladium; Phthalimides

2005
Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, May-20, Volume: 105, Issue:20

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Biological Transport; Biophysics; Cysteine; Fluor

2008